Leslie Lauersdorf insist that it's vital to inform your patients about what's involved in beginning daratumumab treatments, especially because of the lengthy chair time.
Related Items
TOP - March 2022 Vol 15, No 2 published on March 16, 2022 in ASH
TOP - January 2020, Vol 13, No 1 published on January 10, 2020 in Hematologic Cancers
Web Exclusives published on November 5, 2019 in Financial Toxicity, Head and Neck Cancer, Hematologic Cancers, In the News, Leukemia
Last modified: July 22, 2021
